CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 500 enrolled
Drug / intervention
InfraScanner 2000™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03353246
NCT03353246N/ACompleted

Assessment of Accuracy, Precision, and Feasibility of a Handheld Near-Infrared Light Device (InfraScanner 2000™) in Detecting Subdural and Epidural Hematomas in Patients Admitted to Duke University Hospital: A Pilot Study

Duke University·interventional·Posted Nov 27, 2017·Updated Aug 20, 2019

In Brief

A clinical study evaluating InfraScanner 2000™ for Head Trauma and 15 related conditions. Completed, enrolled 500 participants across 1 site.

Detailed Summary

The goal of this study is to determine the sensitivity, specificity, and positive and negative predictive values of the a portable near-infrared-based device (portable NIR-based device), the InfraScanner 2000™, to detect intracranial hematomas (epidural hematomas (EDH) and/or subdural hematomas (SDH)) in patients hospitalized at Duke University Hospital (DUH) who have sustained or who are suspected to have sustained head trauma and have consequently received a brain computed tomography (CT) scan(s).

Study Details

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 27, 2017
Enrollment StartDec 11, 2017
Primary CompletionMay 4, 2018
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 8.6 years ago

Interventions

InfraScanner 2000™device

The Infrascanner is a portable screening device that uses Near-Infrared (NIR) technology to screen patients for intracranial bleeding, identifying those who would most benefit from immediate referral to a CT scan and neurosurgical intervention.